ArticleBreast cancer research : BCR2025

AI-driven MRI biomarker for triple-class HER2 expression classification in breast cancer: a large-scale multicenter study.

Chinting Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.